Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis

While immune checkpoint inhibitors (ICI) can lead to sustained responses in metastatic renal cell carcinoma (mRCC), the optimal duration of therapy remains unknown. We aimed to examine treatment-free survival (TFS) in objective responders who discontinued ICI and to explore factors that may impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tzeng, Alice, Tzeng, Tony H, Ornstein, Moshe C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488739/
https://www.ncbi.nlm.nih.gov/pubmed/34599022
http://dx.doi.org/10.1136/jitc-2021-003473

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488739/
https://www.ncbi.nlm.nih.gov/pubmed/34599022
http://dx.doi.org/10.1136/jitc-2021-003473

Ejemplares similares